Sawsan Rashdan

Hematology | Oncology

5323 Harry Hines Blvd
Dallas, TX 75390

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

HSR26-215: Incomplete Tobacco Use Documentation Limits Lung Cancer Screening Eligibility Among Refugee Patients.

HSR26-215: Incomplete Tobacco Use Documentation Limits Lung Cancer Screening Eligibility Among Refugee Patients.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: April 16, 2026

HSR26-215: Incomplete Tobacco Use Documentation Limits Lung Cancer Screening Eligibility Among Refugee Patients.

HSR26-215: Incomplete Tobacco Use Documentation Limits Lung Cancer Screening Eligibility Among Refugee Patients.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: March 30, 2026

Culturally Competent Oncology Care for Muslim Patients: A Case-Based Narrative Review of Barriers and Clinical Outcomes.

Culturally Competent Oncology Care for Muslim Patients: A Case-Based Narrative Review of Barriers and Clinical Outcomes.

Journal: Cureus

Published: March 17, 2026

Deciphering small sequence differences in T cell receptor-antigen pairing.

Deciphering small sequence differences in T cell receptor-antigen pairing.

Journal: Nature communications

Published: November 05, 2025

The Landscape and Management of Brain Parenchymal and Leptomeningeal Metastases in EGFR Mutated Non-Small Cell Lung Cancer.

The Landscape and Management of Brain Parenchymal and Leptomeningeal Metastases in EGFR Mutated Non-Small Cell Lung Cancer.

Journal: Cancers

Published: June 03, 2025

Osimertinib plus consolidative radiotherapy for advanced EGFR mutant non-small cell lung cancer: a multicentre, single-arm, phase 2 trial.

Osimertinib plus consolidative radiotherapy for advanced EGFR mutant non-small cell lung cancer: a multicentre, single-arm, phase 2 trial.

Journal: EClinicalMedicine

Published: May 08, 2025

Association of PD-L1 expression with systemic immune parameters in non-small cell lung cancer.

Association of PD-L1 expression with systemic immune parameters in non-small cell lung cancer.

Journal: Translational lung cancer research

Published: April 10, 2025

Overcoming Financial and Access Barriers in Global Cancer Care With Low-Dose Immunotherapy: A Systematic Review.

Overcoming Financial and Access Barriers in Global Cancer Care With Low-Dose Immunotherapy: A Systematic Review.

Journal: JCO global oncology

Published: March 24, 2025

Incidence and correlates of high-grade chemotherapy-induced peripheral neuropathy in patients with lung cancer.

Incidence and correlates of high-grade chemotherapy-induced peripheral neuropathy in patients with lung cancer.

Journal: The oncologist

Published: August 28, 2024

Profiling antigen-binding affinity of B cell repertoires in tumors by deep learning predicts immune-checkpoint inhibitor treatment outcomes.

Profiling antigen-binding affinity of B cell repertoires in tumors by deep learning predicts immune-checkpoint inhibitor treatment outcomes.

Journal: Nature cancer

Published: July 15, 2024

Cmai: Predicting Antigen-Antibody Interactions from Massive Sequencing Data.

Cmai: Predicting Antigen-Antibody Interactions from Massive Sequencing Data.

Journal: bioRxiv : the preprint server for biology

Published: July 15, 2024

Concerning Safety and Efficacy of Concurrent and Consolidative Durvalumab With Thoracic Radiation Therapy in PDL1-Unselected Stage III Non-Small Cell Lung Cancer: Brief Report.

Concerning Safety and Efficacy of Concurrent and Consolidative Durvalumab With Thoracic Radiation Therapy in PDL1-Unselected Stage III Non-Small Cell Lung Cancer: Brief Report.

Journal: International journal of radiation oncology, biology, physics

Published: March 12, 2024

Showing 1-12 of 30

Last Updated: 09/26/2026